A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: procedure (650), etiquette (1), practice (609)

Docetaxel-Fluorouracil-Folinic Acid-Oxaliplatin (FLOT)

Description
Chemotherapy Protocol UPPER GASTROINTESTINAL CANCER DOCETAXEL-FLUOROURACIL-FOLINIC ACID-OXALIPLATIN (FLOT) Regimen • Upper GI – Docetaxel-Fluorouracil-Folinic Acid-Oxaliplatin (FLOT) Indication
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Upper-gastro-intestinal/Docetaxel-Fluorouracil-Folinic-Acid-Oxaliplatin-FLOT.pdf

Cetuximab (500)-Fluorouracil-Folinic Acid-Oxalplatin

Description
Chemotherapy Protocol COLORECTAL CANCER CETUXIMAB(500)-FLUOROURACIL-FOLINIC ACID (Modified de Gramont)OXALIPLATIN Regimen This regimen may require funding • Colorectal Cancer
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Cetuximab500-Fluorouracil-FolinicAcid-Oxalplatin.pdf

Cetuximab (500)-Fluorouracil-Folinic Acid-Irinotecan

Description
Chemotherapy Protocol COLORECTAL CANCER CETUXIMAB(500)-FLUOROURACIL-FOLINIC ACID (Modified de Gramont)IRINOTECAN Regimen This regimen may require funding • Colorectal Cancer
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Cetuximab500-Fluorouracil-FolinicAcid-Irinotecan.pdf

Bevacizumab-Capecitabine-Oxaliplatin

Description
Chemotherapy Protocol COLORECTAL CANCER BEVACIZUMAB-CAPECITABINE-OXALIPLATIN This protocol may require funding Regimen • Colorectal Cancer– Bevacizumab-Capecitabine-Oxaliplatin Indication • Metastatic colorectal
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Bevacizumab-Capecitabine-Oxaliplatin.pdf

Procedure for GEM 1 and 2 calorimeter

Description
NIHR Southampton Biomedical Research Centre The NIHR Southampton Biomedical Research Centre (BRC) has a tight quality assurance
Url
/Media/Southampton-Clinical-Research/Procedures/BRCProcedures/Procedure-for-GEM-1-and-2-calorimeter.pdf

Ibrutinib-Venetoclax

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia IBRUTINIB-VENETOCLAX Regimen CLL – Ibrutinib & Venetoclax Indication • Ibrutinib plus Venetoclax is recommended as an option for
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Ibrutinib-Venetoclax-Ver1.1.pdf

B-AVD (Brentuximab vedotin-Dacarbazine-Doxorubicin-Vinblastine)

Description
Chemotherapy Protocol LYMPHOMA BRENTUXIMAB VEDOTIN-DACARBAZINE-DOXORUBICIN-VINBLASTINE (B- AVD) Regimen • Lymphoma – Brentuximab vedotin - Dacarbazine-Doxorubicin-Vinblastine Indication • Previously untreated stage
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/B-AVD-Brentuximab-vedotin-Dacarbazine-Doxorubicin-Vinblastine.pdf

InP-Etoposide-Ifosfamide (3 day) v2

Description
Chemotherapy Protocol SARCOMA ETOPOSIDE-IFOSFAMIDE (3 day) Inpatient Regimen Regimen • Sarcoma-InP-Etoposide-Ifosfamide (3 day) Indication • Second line treatment of
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InP-Etoposide-Ifosfamide-3-day-v2.pdf

AmB-LISOCEL-Cyclophosphamide (300)-Fludarabine (30)

Description
Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY AmB – LISOCEL – CYCLOPHOSPHAMIDE (300) – FLUDARABINE (30) Ambulatory Regimen This regimen is
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/AmB-LISOCEL-Cyclophosphamide-300-Fludarabine-30.pdf

Form 034 Research Sponsorship Intention to Apply Form v3 Aug 2024 Clean

Description
Research Sponsorship Intention to Apply Form Please complete the information below as fully as possible. Section 1 – Applicant Details Title/Nam
Url
/Media/Southampton-Clinical-Research/Grants/Download/Form-034-Research-Sponsorship-Intention-to-Apply-Form-v3-Aug-2024-Clean.docx
321 to 330 of 698
Previous … 31 32 33 34 35 … Next